Skip to main content
Clinical Trials/NCT01736644
NCT01736644
Completed
N/A

A Prospective Randomized Control Trial to Compare the Aquamantys System With Standard Electrocautery in Reducing Blood Loss in Primary Total Knee Arthroplasty

Medtronic Surgical Technologies2 sites in 1 country97 target enrollmentOctober 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Medtronic Surgical Technologies
Enrollment
97
Locations
2
Primary Endpoint
Blood Loss
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study will compare the clinical outcomes for patients undergoing a total knee replacement using a bipolar sealer, the Aquamantys® System, as compared to standard electrocautery. Total blood loss during the hospital stay and knee mobility and discharge factors will be analyzed.

Registry
clinicaltrials.gov
Start Date
October 2012
End Date
October 27, 2013
Last Updated
6 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Sponsor
Medtronic Surgical Technologies
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient is ≥18 years of age
  • Patient has failed conservative therapy of osteoarthritis of the knee and has been listed to undergo primary TKA
  • Patient is willing and able to provide written informed consent.
  • Pre-assessment Haemoglobin ≥ 11.0g/dl
  • Patient is suitable to receive spinal anaesthesia with no peripheral nerve blocks
  • Patients willing to undergo blood transfusion

Exclusion Criteria

  • Patients that are listed for unicondylar or revision TKA
  • Patients who are being converted from a previous high tibial osteotomy and a previous unicondylar knee arthroplasty
  • Fixed motor deficit thus affecting functional assessment of the knee
  • Patients presenting with a non-osteoarthritis degenerative knee diagnosis
  • Patients presenting with known contralateral knee osteoarthritis requiring simultaneous bilateral TKA
  • Patients presenting with a history of previous knee infection
  • Patients presenting with a pre-operative knee range of motion \< 85°
  • Knee deformity greater than 20 degrees varus or valgus
  • Patients presenting with a history of bleeding disorders and/or are on chronic blood anticoagulation therapy
  • Patients with significantly impaired renal function (defined by EGFR \>30)

Outcomes

Primary Outcomes

Blood Loss

Time Frame: upto to 72 hrs after surgery

The primary outcome will be total blood loss throughout the hospital stay.

Secondary Outcomes

  • Rehabilitation(6-weeks)

Study Sites (2)

Loading locations...

Similar Trials